| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Anatomy and Cell Biology and Cardiovascular Center, University of Iowa, Iowa City, Iowa 52242; and 2 Department of Medical Physiology, Texas A&M University, and System Health Science Center, College Station, Texas 77843
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
To test the hypotheses that cyclic stretch of
1) cardiac myocytes produces factors that trigger angiogenic
events in coronary microvascular endothelial cells (CMEC) and
2) CMEC enhances the expression of growth factors, cardiac
myocytes and CMEC were subjected to cyclic stretch in a
Flexercell Strain Unit. Vascular endothelial growth factor
(VEGF) but not basic fibroblast growth factor mRNA and protein levels
increased approximately twofold in myocytes after 1 h of stretch.
CMEC DNA synthesis increased approximately twofold when conditioned
medium from stretched myocytes or VEGF protein was added, and addition
of VEGF neutralizing antibody blocked the increase. CMEC migration and
tube formation increased with the addition of conditioned media but
were markedly attenuated by VEGF neutralizing antibody. Myocyte tumor
growth factor-
(TGF-) increased 2.5-fold after 1 h of
stretch, and the addition of TGF- neutralizing antibodies inhibited
the stretch-induced upregulation of VEGF. Stretch of CMEC increased
VEGF mRNA in these cells (determined by Northern blot and RT-PCR) and
increased the levels of VEGF protein (determined by ELISA analysis) in
the conditioned media. Therefore, cyclic stretch of cardiac myocytes
and CMEC appears to be an important primary stimulus for coronary
angiogenesis through both paracrine and autocrine VEGF pathways. These
data indicate that 1) CMEC DNA synthesis, migration, and
tube formation are increased in response to VEGF secreted from
stretched cardiac myocytes; 2) VEGF in CMEC subjected to
stretch is upregulated and secreted; and 3) TGF-
signaling may regulate VEGF expression in cardiac myocytes.
cardiac myocytes; endothelial cells; basic fibroblast growth
factor; cell migration; cell proliferation; vascular endothelial growth
factor; tumor growth factor-
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
OUR KNOWLEDGE CONCERNING ANGIOGENESIS has been advanced by identifying growth factors and other molecules that initiate and regulate a cascade of events leading to neovascularization. Although the primary stimuli that activate angiogenic molecules have not been established for all models of angiogenesis, metabolic and mechanical factors are implicated as stimuli for both angiogenesis and vascular remodeling (reviewed in Ref. 8, 15, and 29). Previous work in our laboratory and reports by others suggest that mechanical factors play a major role in coronary angiogenesis (reviewed in Ref. 31). Taken together, data from these studies indicate that coronary angiogenesis is an adaptation to either increased coronary blood flow or increased diastolic filling. These findings provided the rationale for the hypothesis that stretch of the ventricular wall might trigger angiogenesis.
Evidence that vascular endothelial growth factor (VEGF), a key
angiogenic factor, is upregulated by stretch of the ventricular wall
was provided by Li and colleagues (18), who found a marked increase in VEGF mRNA after diastolic pressure had been increased to 35 mmHg for 30 min in an isolated Langendorff preparation. They also
showed that this increase was mediated, at least in part, by tumor
growth factor- (TGF-). To test the hypothesis that myocardial
angiogenesis is a response to enhanced diastolic filling in a
nonhypertrophic model, we administered the bradycardia drug
alinidine to young rats for a period of 3 wk (37). Our data documented an increase in VEGF mRNA associated with the myocardial angiogenesis, i.e., a 23% increase in capillary length density. When
VEGF neutralizing antibodies were administered to the bradycardia group, angiogenesis was completely prevented.
Evidence that stretch is a stimulus for growth factors has emerged from
in vitro studies. Cyclic stretch triggers TGF- secretion in
mesangial (25) and smooth muscle (19) cells.
The demonstration that VEGF secretion in rat cardiomyocytes occurs in
response to cyclic stretch has provided direct evidence that stretch
per se provides a trigger for VEGF secretion in this cell type
(28). The current study was designed to test two
hypotheses based on these findings. First, we tested the hypothesis
that specific angiogenic events in coronary microvascular endothelial
cells (CMEC) are triggered by stretch-activated growth factors in
cardiomyocytes, which provide paracrine signals for CMEC. Second, we
tested the hypothesis that stretch of endothelial cells serves to
trigger autocrine signaling by growth factors.
| |
MATERIALS AND METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Cardiac myocyte cultures Primary cardiac myocyte cultures were prepared from ventricles of 2-day-old Sprague-Dawley rats, with modifications of the protocol described previously (1). Briefly, minced ventricular myocytes were placed into potassium glutamate solution [containing (in mM) 140 potassium glutamate, 16 NaHCO3, 0.5 NaH2PO4, 25 HEPES, 16.5 dextrose, and 0.014 phenol red], which was obtained from the Hybridoma Facility at the University of Iowa. Cell dispersion was accomplished by digestion with 0.3% collagenase and then with 0.1% trypsin at 37°C for 10 min. The suspension from the first treatment was discarded, and the sequence was repeated until all tissue was dissociated. The dissociated cells were preplated into a 100-mm culture dish for 1 h in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) to reduce the number of contaminating nonmuscle cells. Cardiomyocyte-enriched suspensions were removed from the culture dish and plated on collagen I Bioflex plates (Flexcell International, Hillsborough, NC) at a density of 1×105 cells/ml. Primary cardiac myocytes were cultured for 48 h in 10% FBS-DMEM containing 1 mM sodium pyruvate and antibiotics. More than 90% of the cells were beating at the end of the experiment.
H9C2(2-1) rat embryo heart myoblasts were purchased from American Type Culture Collection and were grown under the same experimental conditions as the primary cardiac myocytes. For the serum-free condition, cells were washed with PBS and maintained in DMEM containing insulin-transferrin-selenium A (Life Technologies, Rockville, MD) for 16-20 h and then stretched.Coronary microvascular endothelial cell cultures. CMEC were isolated by collagenase perfusion as previously described (34). Briefly, after the rat was anesthetized and heparinized, the hearts were removed and placed in ice-cold minimal essential medium (Joklik's modified buffer) and 5 mM HEPES and perfused using a static 40-mmHg hydrostatic pressure head. After a 10-min washout period, collagenase (0.7 mg/ml) was introduced to the perfusate and allowed to recirculate for 30-40 min. The ventricles were minced and placed in fresh collagenase-containing perfusate, and CaCl2 (50 µM) was added. The cells were dispersed, filtered through a double layer of cheesecloth, and diluted 1:4 with buffer containing 0.1% of dialyzed bovine serum albumin. The resulting suspension was allowed to settle to separate the myocytes from CMEC. Further purification of CMEC was accomplished by sequential filtration through a series of 90-, 45-, 25-, and 15-µm nylon screens. We confirmed CMEC identity by the uptake of modified low-density lipoprotein and/or positive staining for factor VIII-related antigen.
CMEC from two to four hearts were pooled into one 60-mm gelatin-coated culture dish. Endothelial cells were cultured at 37°C under 10% CO2 in 3 ml DMEM supplemented with 20% FBS, 2 mM L-glutamine, 20 mM D-glucose, 20 U/ml heparin, 1 mM sodium pyruvate, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B. After the cells neared confluence, they were passaged by trypsinization in Dulbecco's PBS containing 0.25% trypsin and 0.02% EDTA and were used for experiments at passages 7-9. The cells were replated in various culture dishes depending on the experimental protocol.Stimulation of cardiac myocytes and endothelial cells. To produce cyclic stretch in vitro, we employed a computerized Flexercell Strain Unit (Flexcell International). Cardiac myocytes or CMEC were seeded on a Bioflex culture plate with a type I collagen substrate. After serum starvation for 16 h, cultured cells were subjected to a 10% average surface elongation at 30 cycles/min (1-s stretch/1-s relaxation) for various time periods. This protocol was selected to provide a dynamic near-physiological strain stimulus. Cultured cells not subjected to cyclic stretch were used as controls.
To determine the role of TGF-, this protein (1 or 10 ng/ml; R&D
Systems, Minneapolis, MN) was added to the medium of cultured myocytes
for a period of 4 h. To determine whether VEGF mRNA expression is
dependent on TGF-, we added TFG- neutralizing antibodies (20 µg/ml; R&D Systems) to the medium before stretching the cells.
Northern blot assay.
Northern blot analysis was used to quantify the abundance of VEGF,
basic fibroblast growth factor (bFGF), and TGF- mRNA in the cultured
cells by modification of the method described previously (37). Briefly, total RNA was extracted from cardiocytes
and CMEC using a STAT-60 (TEL-TEST "B", Friendswood, TX). Total RNA (10 µg) was separated in a 1.2% formaldehyde-agarose gel,
transferred to nylon membrane by capillary blot, and fixed by
ultraviolet cross-linking. Prehybridization of the filters was
conducted for 1-2 h at 55°C in 50% formamide, 5× saline-sodium
citrate (SSC), 4× Denhardt's solution, 1% SDS, 10% dextran sulfate,
and 150 µg/µl heat-denatured, sheared salmon sperm DNA. Northern
blot hybridization was performed with a random 32P-labeled
630-bp cDNA fragment of rat VEGF (the kind gift of Dr. Kenneth Thomas,
Merck Research Laboratories), a 400-bp fragment of bFGF cDNA, or 416-bp
fragment of rat TGF-1 cDNA (36) at 42°C
overnight. After incubation, the blots were washed in 1× SSC-1% SDS
for 10 min at room temperature, followed by two 30-min washes in 0.2×
SSC-1% SDS at 55°C, and then exposed to X-ray film (Fuji NIF film,
Fisher Scientific, Pittsburgh, PA) at 
70°C. Autoradiagrams were
scanned using Adobe Photoshop 5.0, and a single band of either VEGF, bFGF, or TGF- mRNA was normalized for each sample with respect
to the density of the corresponding 18S mRNA signal to compensate for
potential variation in RNA loading and transfer.
Western blot assay. For analysis of VEGF protein expression in cardiac myocytes, cells were lysed by addition of 0.5 ml radioimmunoprecipitation buffer [1% NP-40, 0.5% sodium deoxycholic acid, 0.1% SDS in PBS (pH 7.4), 1 µmol/l leupeptin, 5 µmol/l aprotinin, 1 mmol/l phenylmethylsulfonyl fluoride, and 1 µmol/l pepstatin] per each Flexcell plate well. Protein extracts (50 µg) were separated with 10% SDS-PAGE, transferred to a nitrocellulose membrane (Schleicher and Schuell, Keene, NH) by electrotransfer, and blocked with 5% nonfat milk for 1 h at room temperature. The blots were incubated with VEGF rabbit polyclonal IgG (Santa Cruz Biotechnology, San Cruz, CA) diluted 1:500 in 1% milk and 0.05% Tris-buffered saline-Tween 20. The antigen-antibody complexes were visualized using anti-rabbit IgG-horseradish persoxidase (Santa Cruz Biotechnology) diluted 1:5,000 and an enhance chemiluminescence detection system (Santa Cruz Biotechnology).
ELISA. VEGF levels in conditioned medium from unstretched and stretched CMEC were detected by ELISA (R&D Systems). Briefly, standards consisting of recombinant mouse VEGF were used at concentration of 0-1,000 pg/ml. VEGF standards and samples were pipetted into wells coated with antibody specific for mouse VEGF (cross-reaction with rat VEGF). After any unbound substances were washed away, an enzyme-linked polyclonal antibody specific for VEGF was added to the wells. After a wash, a substrate solution was added. The absorbance of standards and samples was measured spectrophotometrically at 450 nm using a microplate reader. VEGF concentrations were calculated (in pg/ml) on the basis of the standard curve.
Preparation of conditioned media. Conditioned media were collected from cardiac myocytes that had been cultured under cyclic stretch for 1 h or nonstretch conditions, centrifuged at 1,000 g for 10 min, and then passed through a 0.22-µm filter. Some of conditioned medium was absorbed with VEGF neutralizing antibody (R&D Systems) for 30 min before use in CMEC. Conditioned medium was added to CMEC that had been washed in PBS.
Endothelial cell proliferation assay. DNA synthesis was estimated by quantifying the incorporation of [methyl-3H]thymidine into trichloroactive acid-insoluble macromolecules. CMEC were seeded onto gelatin-coated membranes in wells and covered with DMEM supplemented with 20% FBS, and, after they approached confluence, they were arrested for 16 h in serum-free DMEM containing 0.1% BSA. They were then incubated for an additional 24 h with media from the following: 1) stretched or unstretched myocytes, 2) 20 ng/ml VEGF, or 3) a mixture of medium from stretched myocytes plus 20 µg/ml VEGF neutralizing antibody. After 1 µCi [3H]thymidine was added per well, the labeled cells were washed with ice-cold PBS, fixed in ice-cold 10% trichloroacetic acid, and then lysed in 0.3 N NaOH. The incorporated [3H]thymidine was measured in 6 ml of counting cocktail 3a70B (Research Products, Mount Prospect, IL) in a liquid scintillation counter (Beckman Instruments).
In vitro migration of endothelial cells. Conditioned media were obtained from stretched or nonstretched myocytes as described for the proliferation studies. CMEC migration assays (4, 13) were performed in a 12-well analytic membrane invasion culture system (MICS) using a 10-µm gelatin-soaked polycarbonate membrane (Osmonics, Livermore, CA). Conditioned medium alone or conditioned medium containing 20 µg/ml of VEGF neutralizing antibody in DMEM supplemented with 0.1% BSA was placed in the lower wells of the MICS chamber. Subconfluent CMEC cultures were washed and trypsinized for the minimum time required to achieve cell detachment. After the filter was placed between the lower and upper chambers, 1×105 cells/ml of DMEM containing 0.1% BSA were seeded in the upper chamber and incubated for 6 h at 37°C in a humidified incubator with 5% CO2. CMEC that had migrated to the lower chamber were trypsinized and collected onto a polylysine-treated 3-µm polycarbonate membrane by filtration in a Schleicher and Schuell minifold 1 apparatus. The cells were then fixed with methanol and stained using a Leukostat staining kit (Fisher Scientific, Pittsburgh, PA). The cells were examined microscopically for intactness and scored by counting 6-10 randomly selected high-power fields.
Endothelial cell tube formation. Three-dimentional cultures were established as described (27) with minor modifications. To observe tube formation in vitro, rat tail type collagen (1.5 mg/ml) was mixed with 2× medium 199 (M199) and neutralized with 1 N NaOH and 300 µl/well of collagen mixture, added to a four-well plate, and allowed to gel for 1 h in a humidified incubator at 37°C. After polymerization, the gels were soaked in DMEM containing 10% FBS for 30 min at 37°C. CMEC (1×105 cell/ml) were plated onto the gel in wells that contained conditioned medium from either stretched or unstretched myocytes, as described above. CMEC were allowed to form tubelike structures for 6-8 days in three-dimensional culture and were then photographed.
The collagen gels with tubelike structures were washed with 0.1 M sodium cacodylate buffer (pH 7.4), fixed in 2.5% gluteraldehyde for 1 h at room temperature, incubated in 1% osminum fixative for another 1 h, and washed again with sodium cacodylate buffer. The samples were dehydrated through a series of acetone and embedded in Spurrs. Ultra-thin sections, stained with 5% uranyl acetate and saturated lead citrate, were observed with a Hitachi 7000 transmission electron microscope.RT-PCR. Total RNA (2 µg) from CMEC was reverse transcribed in 20 µl of reaction volume containing 250 ng of random primers, 0.5 mmol/l each dNTP, 50 mmol/l Tris · HCl (pH 8.3), 75 mmol/l KCl, 3 mmol/l MgCl2, 10 mmol/l dithiothreitol, and 200 units of moloney murine leukemia virus reverse transcriptase (Life Technologies). After 1 h of incubation at 37°C, samples were heated to 80°C for 10 min and then chilled on ice. Thermal cycling of 2 µl of cDNA from the reverse transcriptase mix was performed using the following specific primers for rat VEGF: sense, 5'CCAGCACATAGGAGAGATGAGCTTC-3'; and antisense, 5'-GGTGTGGTGGTGACATGGTTAATC-3'. PCR resulted in three bands (262, 394, and 466 bp) corresponding to the three principal VEGF isoforms 120, 164, and 188, respectively, expressed in the rat (5, 7, 9). Coamplification of the same DNA was performed for rat glyceraldehyde 3-phosphate dehydrogenase as an internal standard with the following primers: sense, 5'-AGGTCGGTGTCAACGGATTT-3'; and antisense, 5'-CAGCATCAAAGGTGGAGGAA-3'. Primers, obtained from the DNA facility at the University of Iowa, were added to the reaction mixture containing 50 mmol/l of Tris · HCl (pH 8.3), 1.5 mmol/l MgCl2, 50 mmol/l KCl, 0.2 mmol/l of each dNTP, and 2.5 units of Taq polymerase in a final volume of 50 µl. Amplication was performed in a thermocycler using the following parameters: 94°C for 1 min, 57°C for 1 min, and 72°C for 1 min (30 cycles). The products were separated on a 1.2% agarose gel together with 100-bp DNA ladder, and the bands were visualized with ethidium bromide. The bands were excised, and their DNA sequences were determined.
Statistical analysis.
Values are expressed as means ± SE. ANOVA and the
t-test followed by a Bonferroni adjustment for multiple
comparisons were used for comparisons of more than two groups.
Significance of mean differences was noted when P 
0.05.
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Stretch induces VEGF gene expression and protein upregulation in
cardiac myocytes.
Primary cardiac myocytes and H9C2(2-1) myoblasts were
serum deprived for 16-20 h before the experiment and then exposed
to cyclic stretch (10% elongation and 30 cycles/min) for various time
periods. VEGF mRNA expression was determined over an 18-h time period.
As illustrated in Fig. 1A,
VEGF mRNA levels in both cell types were upregulated by stretch with a
similar time course, as evidenced by a 1.6-fold increase in both cell
types. A significant increase (P < 0.01) was noted
after only 30 min of stretch and was maintained for 6 h, with
maximal levels (2.3- to 2.5-fold) occurring at 1 h. VEGF protein
levels, determined by immunobloting, were higher in stretched than
nonstretched myocytes (Fig. 1B). The increased levels in
response to stretch occurred in a similar time-dependent manner in both
types of myocytes, with the increase apparent as early as 30 min after
initiation of stretch. Maximal levels occurred at 1 h [1.9-fold,
P < 0.01; or 2.3-fold, P < 0.01 in
primary cardiac myocytes and a H9C2(2-1) cell,
respectively] and then remained elevated up to 18 h.
|
TGF- plays a role in stretch-induced upregulation of VEGF.
With the use of Northern blot analysis, we found that mRNA levels of
TGF- increased 2.5-fold in cardiac myocytes after 1 h of
stretch (Fig. 2A). We then
showed that both stretch and exogenous TGF- (1 or 10 ng/ml) induced
the upregulation of VEGF mRNA (Fig. 2B). When anti-TGF-
neutralizing antibodies were added to the culture medium and the
myocytes were then stretched, the stretch-induced VEGF expression was
totally inhibited, indicating that VEGF upregulation in response to
stretch is dependent on TGF-. Addition of anti-TBF- neutralizing
antibodies to nonstretched myocytes had no effect on VEGF mRNA. In
contrast, as seen in Fig. 3, bFGF mRNA
was not significantly altered in myocytes subjected to stretch,
although slightly higher values were noted 1-18 h after initiation
of stretch compared with the controls.
|
|
VEGF from stretched myocytes induces proliferation of endothelial
cells.
Because VEGF has been previously shown to stimulate proliferation,
migration, and tube formation of endothelial cells, we hypothesized
that VEGF, released from stretched myocytes, might stimulate these
angiogenic characteristics in our model. As shown in Fig.
4, conditioned medium in which myocytes
were stretched for 1 h increased CMEC DNA synthesis more than
twofold over the control group. Addition of recombinant
VEGF165 (20 ng/ml) to the CMEC medium had a similar effect.
VEGF neutralizing antibody (20 µg/ml) resulted in an almost total
block of conditioned medium-stimulated proliferation, suggesting that
soluble VEGF produced by the stretched myocyte mediates proliferation
in CMEC via a paracrine mechanism.
|
Conditioned medium from stretched myocytes increases endothelial
cell migration and tube formation.
The impact of conditioned medium on endothelial cell migration, shown
in Fig. 5, indicates that the conditioned
medium from myocytes markedly increases CMEC migration
(P = 0.004). Addition of VEGF neutralizing antibodies
to the medium inhibited the more than twofold increase by 60%
(P < 0.05). We then tested the hypothesis that tube
formation by CMEC is enhanced by the conditioned media from stretched
myocytes. Accordingly, CMEC were seeded on the three-dimensional
type I collagen gels and exposed to basal media (Fig.
6A), conditioned medium from
nonstretched myocytes (Fig. 6B), or conditioned medium from
stretched myocytes (Fig. 6C). Media were changed daily.
After 6-8 days of treatment, endothelial cells cultured in either
basal medium or medium from unstretched cells were minimally spread and
did not form networks of cell cords. In contrast, CMEC stimulated with
media from stretched myocytes appeared in networks of cords. That these
cell cords formed tubular structures was verified by transmission
electron microscopy (Fig. 6E). The organization of CMEC into
networks and tube structures in the conditioned medium from stretched
myocytes was inhibited by addition of VEGF neutralizing antibodies to
the conditioned medium (Fig. 6D). VEGF antibodies not only
partially inhibited tube formation but also decreased the number of
cells. Thus the latter observation suggests that VEGF may stimulate
CMEC proliferation and/or facilitate survival of these cells.
|
|
Stretch-induced VEGF expression in CMEC.
To test the hypothesis that VEGF is upregulated by stretch of CMEC, we
determined VEGF mRNA over time during cyclic stretch. The protocol was
identical to that used for myocyte cyclic stretch. As shown in Fig.
7A, VEGF mRNA was increased
1.4-fold 1 h after stretch and then declined. RT-PCR analysis
(Fig. 7B) confirmed induction of all three major VEGF
isoforms in CMEC. To document increased VEGF protein secretion by
stretched CMEC, we measured the protein in the conditioned media of
stretched and nonstretched CMEC (Fig. 8).
The data illustrate that VEGF protein significantly increased after
1 h of stretch and increased two- and fivefold by 6 and 18 h
of stimulation, respectively. Thus stretch of CMEC provides a potential
autocrine mechanism for VEGF.
|
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Previous work (18) indicated that distention of the
ventricle upregulates VEGF in the heart and that TGF- plays a role in this upregulation. Subsequently, cyclic stretch was found to stimulate VEGF secretion in isolated cardiac myocytes. On the basis of
this background, we tested hypotheses regarding paracrine angiogenic
signals from stretched cardiac myocytes and autocrine signaling from
stretched endothelial cells. Our data provide new evidence that
angiogenic factors from cardiac myocytes subjected to stretch enhance
the following critical angiogenic events in CMEC: DNA synthesis,
migration, and tube formation. VEGF upregulation by stretch is mediated
by TGF-, because upregulation of the former was prevented by
blocking the later with neutralizing antibodies. A second major finding
is that stretch of CMEC upregulates VEGF.
Endothelial cells are subjected to mechanical forces, which alter their
functional and structural properties, i.e., mechanotransduction (reviewed in Ref. 8). Such forces include shear stress,
pressure, and stretch. Our experiments were based on the hypothesis
that stretch within the ventricular wall constitutes a mechanical force that triggers the synthesis and release of growth factors as well as
the cascade of angiogenic events leading to microvessel formation. This
hypothesis was supported by our recent work that documented a
VEGF-dependent angiogenesis in an in vivo model of enhanced diastolic
filling associated with bradycardia (37) and by the finding that distension of the ventricle in an ex vivo system stimulates VEGF upregulation (18). Seko et al.
(28) recently showed that cyclic stretch of cardiac
myocytes can induce VEGF secretion, which is, at least in part,
mediated by TGF-. Our data are in agreement with these findings.
To our knowledge, our experiments are the first demonstration that
cardiac myocytes subjected to stretch release factors that directly
evoke 1) DNA synthesis, 2) migration, and
3) tube formation by CMEC. We also documented that the
conditioned media from myocytes subjected to cyclic stretch, which
increased DNA synthesis in the CMEC by about the same magnitude as
addition of VEGF, could be blocked by the addition of anti-VEGF
neutralizing antibodies to the conditioned media. Thus proliferation of
CMEC is dependent on VEGF signaling. In contrast, addition of the
neutralizing antibodies to the conditioned media from stretched
myocytes in the migration assay markedly limited, but did not abolish,
the increase in CMEC migration, a finding suggesting that another
promigratory factor(s) is released by the stretched myocytes. VEGF
upregulation in myocytes is dependent on TGF-, because the addition
of TGF- neutralizing antibodies completely negates the VEGF increase
in myocytes subjected to stretch, a finding that is in agreement with
Seko et al. (28). However, we noted that addition of 10 ng
of TGF- protein elicited a smaller increase in VEGF mRNA than did 1 ng of the protein. This finding is consistent with previous work on
endothelial cells in vitro, which showed that low doses of TGF-
stimulate angiogenic events, whereas high doses are inhibitory
(24). Although the increase in VEGF mRNA associated with
TGF- is probably due to increased transcription, we cannot rule out
the possiblity that the increase is due to a longer half-life of the
message. Both latent and active forms are elevated when smooth muscle
cells are stretched (19).
Mechanical stretch has previously been shown to stimulate growth of
neonatal cardiac myocytes (2) and to increase the
activities of mitogen-activated protein (MAP) kinase, S6 peptide
kinase, c-fos mRNA, and protein synthesis (17, 35).
Stretch of cardiac myocytes was shown to rapidly activate several
second messenger pathways in addition to Ras/MAP kinase, e.g., tyrosine
kinases, protein kinase C, and phospholipase C and D, but not cAMP
(26). Moreover, stretch has been shown to activate all
three MAP kinase family members, extracellular signal-regulated protein
kinase, and the focal adhesion kinase p125 (28). That
study also demonstrated that VEGF and TGF- are, at least partially,
responsible for extracellular signal-regulated protein kinase
activation by stretch. Thus the recruitment of VEGF and TGF- by
stretch is documented by these investigators as well as our own data.
Stretch also has been shown to increase TGF- (25) and
VEGF production (12) in mesangial cells. In vascular
smooth muscle cells, stretch increases TGF- secretion
(19) and phosphorylates the platelet-derived growth factor-
receptor (14). These data indicate that growth
factors in several cell types are triggered by stretch.
Our finding that stretch of CMEC upregulates VEGF is not only novel but perhaps unexpected, because endothelial cells do not express VEGF under normal conditions. However, under hypoxic conditions, endothelial cells have been shown to express (20) and secrete (23) VEGF. Stretch affects changes in endothelial cells, which may promote their growth, e.g., via prostacyclin accumulation (21) and alignment of stress fibers along the long axis of the cell (38). It has also been postulated that stretch inhibits protein phosphatase 2A, a growth suppressor (22).
The role of blood flow in angiogenesis during development was demonstrated during the early 1900's (6, 30). Capillary growth has been found to occur when blood flow is increased in the heart via chronic administration of a vasodilator (33) and in skeletal muscle via electrical stimulation (15). Although increased blood flow may enhance capillary growth by shear stress, wall tension, or stretch (16), our in vitro data show that stretch in the absence of the other flow-related forces acts as a primary stimulus for activation of angiogenesis. This evidence is consistent with in vivo experiments that demonstrated chronic stretch of skeletal muscle in the absence of enhanced blood flow stimulated marked capillary proliferation (10, 23).
Although the role of hypoxia in upregulation of VEGF is well established (reviewed in Ref. 11), concrete evidence that stretch also plays a similar role is relatively new (18, 28). Accordingly, both metabolic and mechanical factors serve to activate VEGF and the angiogenic cascade. During heart development, both can be considered as potential activators of vascularization because rapid increases in cardiac mass could cause focal hypoxia and could also stretch developing vascular structures. Studies in adult hearts have induced angiogenesis under conditions of exercise training, dipyridamole treatment, arteriovenous shunts, thyroid hormone treatment, and chronic bradycardia (reviewed in Ref. 32). These models are associated with either increased coronary flow or enhanced diastolic filling, both of which provide mechanical stimuli for angiogenesis. With the use of the arteriovenous shunt model, we demonstrated growth of both capillaries and arterioles (3). On the basis of the findings of these studies and those of the current study, there is ample evidence to suggest that interventions that encompass mechanical factors, e.g., stretch, may be clinically useful in promoting myocardial vascularization.
| |
ACKNOWLEDGEMENTS |
|---|
The authors are indebted to Dr. Tommy Brock and Texas Biotechnology for providing the VEGF neutralizing antibodies and to Dr. Mark Chapleau for use of the Flexercell unit. CMEC were isolated with the technical assistance of Tony E. Haynes.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-4896 and HL-62178.
Address for reprint requests and other correspondence: R. J. Tomanek, Dept. of Anatomy and Cell Biology, Bowen Science Bldg., Univ. of Iowa, Iowa City, IA 52242 (E-mail: robert-tomanek{at}uiowa.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 24 January 2000; accepted in final form 11 September 2000.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Atkins, DL,
Krumm PA,
Schutte BC,
Harrison JD,
and
Green SH.
Regulation of rat cardiac myocyte growth by a neuronal factor secreted by PC12 cells.
Pediatr Res
41:
832-841,
1997[Web of Science][Medline].
2.
Cadre, BM,
Qi M,
Eble DM,
Shannon TR,
Bers DM,
and
Samarel AM.
Cyclic stretch down-regulates calcium transporter gene expression in neonatal rat ventricular myocytes.
J Mol Cell Cardiol
30:
2247-2259,
1998[Web of Science][Medline].
3.
Chen, Y,
Torry RJ,
Baumbach GL,
and
Tomanek RJ.
Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload.
Am J Physiol Heart Circ Physiol
267:
H2132-H2137,
1994
4.
Chu, YW,
Runyan RB,
Oshima RG,
and
Hendrix MJC
Expression of complete keratin filaments in mouse L cells augments cell migration and invasion.
Proc Natl Acad Sci USA
90:
4261-4265,
1993
5.
Chua, CC,
Hamdy RC,
and
Chua BH.
Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells.
Biochim Biophys Acta
1401:
187-194,
1998[Medline].
6.
Clark, ER.
Studies on the growth of blood vessels in the tail of the frog.
Am J Anat
23:
37-88,
1918[Web of Science].
7.
Conn, G,
Bayne ML,
Soderman DD,
Kwok PW,
Sullivan KA,
Palisi TM,
Hope A,
and
Thomas KA.
Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor.
Proc Natl Acad Sci USA
87:
2628-2632,
1990
8.
Davies, PF,
and
Tripathi SC.
Mechanical stress mechanisms and the cell. An endothelial paradigm.
Circ Res
72:
239-245,
1993
9.
Edelman, JL,
Castro MR,
and
Wen Y.
Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.
Invest Ophthalmol Vis Sci
40:
1112-1123,
1999
10.
Egginton, S,
Hudlicka O,
Brown MD,
Walter H,
Weiss JB,
and
Bate A.
Capillary growth in relation to blood flow and performance in overloaded rat skeletal muscle.
J Appl Physiol
85:
2025-2032,
1998
11.
Ferrara, N,
and
Davis-Smyth T.
The biology of vascular endothelial growth factor.
Endocr Rev
18:
4-25,
1997
12.
Gruden, G,
Thomas S,
Burt D,
Zhou W,
Chusney G,
Gnudi L,
and
Viberti G.
Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells.
J Am Soc Nephrol
10:
730-737,
1999
13.
Hendrix, MJC,
Seftor EA,
Seftor REB,
and
Fidler IJ.
A simple quantitative assay for studying in invasive potential of high and low metastatic variants.
Cancer Lett
38:
137-147,
1987[Web of Science][Medline].
14.
Hu, Y,
Bock G,
Wick G,
and
Xu Q.
Activation of PDGF- receptor in vascular smooth muscle cells by mechanical stress.
FASEB J
12:
1135-1142,
1998
15.
Hudlicka, O,
and
Brown MD.
Physical forces and angiogenesis.
In: Mechanoreception by the Vascular Wall, , edited by Rubanyi GM.. Kisko, NY: Futura, 1993, p. 197-241.
16.
Hudlicka, O,
and
Tyler KR.
The effect of long-term high frequency stimulation on capillary density and fibre types in rabbit fast muscle.
J Physiol (Lond)
353:
435-445,
1984
17.
Kashiwagi, Y,
Haneda T,
Osaki J,
Miyata S,
and
Kikuchi K.
Mechanical stretch activates a pathway linked to mevalonate metabolism in cultured neonatal rat heart cells.
Hypertens Res
21:
109-119,
1998[Web of Science][Medline].
18.
Li, J,
Hampton T,
Morgan JP,
and
Simons M.
Stretch-induced VEGF expression in the heart.
J Clin Invest
100:
18-24,
1997[Web of Science][Medline].
19.
Li, Q,
Muragaki T,
Hatamura I,
Ueno H,
and
Ooshima A.
Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-.
J Vasc Res
35:
93-103,
1998[Web of Science][Medline].
20.
Liu, Y,
Cox SR,
Morita T,
and
Kourembanas S.
Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer.
Circ Res
77:
638-643,
1995
21.
MacArthur, H,
Warner TD,
Wood EG,
Corder R,
and
Vane JR.
Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch.
Biochem Biophys Res Commun
200:
395-400,
1994[Web of Science][Medline].
22.
Murta, K,
Mills I,
and
Sumpio BE.
Protein phosphatase 2A in stretch-induced endothelial cell proliferation.
J Cell Biochem
63:
311-319,
1996[Web of Science][Medline].
23.
Nomura, M,
Yamagishi S,
Harada S,
Hayashi Y,
Yamashima T,
Yamashita J,
and
Yamamoto H.
Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes.
J Biol Chem
270:
28316-28324,
1995
24.
Pepper MS, Vassalli JD, Orci L, and Montesano R. Biphasic effect
of trans forming growth factor-beta 1 on in vitro angiogenesis.
Exp Cell Res 204: 356-363.
25.
Riser, BL,
Cortes P,
Yee J,
Sharba AK,
Asano K,
Rodriguez-Barbero A,
and
Narins RG.
Mechanical strain- and high glucose-induced alterations in mesangial cell collagen metabolism: role of TGF-.
J Am Soc Nephrol
10:
827-836,
1997.
26.
Sadoshima, J,
and
Izumo S.
Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism.
EMBO J
12:
1681-1692,
1993[Web of Science][Medline].
27.
Sankar, S,
Mahoots-Brooks N,
Bensen L,
McCarthy TL,
Centrella M,
and
Madri JA.
Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis.
J Clin Invest
97:
1436-1446,
1996[Web of Science][Medline].
28.
Seko, Y,
Seko Y,
Takahashi N,
Shibuya M,
and
Yazaki Y.
Pulsatile stretch stimulated vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes.
Biochem Biophys Res Commun
254:
462-465,
1999[Web of Science][Medline].
29.
Skalak, TC,
and
Price RJ.
The role of mechanical stresses in microvascular remodeling.
Microcirculation
3:
143-165,
1996[Medline].
30.
Thoma, R.
Uber die Histomechanik des Gefassystems und die Pathogenese der Angiosklerose.
Virchows Arch
204:
1-74,
1911.
31.
Tomanek, RJ.
Angiogenesis in nonischemic myocardium. In: Angiogenesis and Cardiovascular Disease, edited by Ware JA,
and Simons M.. New York: Oxford University Press, 1999, p. 199-212.
32.
Tomanek, RJ,
and
Torry RJ.
Growth of the coronary vasculature in hypertrophy. Mechanisms and model dependence.
Cell Mol Biol Res
40:
129-136,
1994[Web of Science][Medline].
33.
Torry, RJ,
O'Brien DM,
Connell PM,
and
Tomanek RJ.
Dipyridamole-induced capillary growth in normal and hypertrophic hearts.
Am J Physiol Heart Circ Physiol
262:
H980-H986,
1992
34.
Wu, G,
and
Meininger CJ.
Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat.
Am J Physiol Heart Circ Physiol
269:
H1312-H1318,
1995
35.
Yamazaki, T,
Tobe K,
Hoh E,
Maemura K,
Kaida T,
Komura I,
Tamemoto H,
Kadowaki T,
Nagai R,
and
Yazaki Y.
Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes.
J Biol Chem
268:
12069-12076,
1993
36.
Zhao, W,
O'Malley Y,
and
Robbins M.
Irradiation of rat mesangial cells alters the expression of gene products associated with development of renal fibrosis.
Radiat Res
152:
160-169,
1999[Web of Science][Medline].
37.
Zheng, W,
Brown MD,
Brock TA,
Bjercke RJ,
and
Tomanek RJ.
Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor.
Circ Res
85:
192-198,
1999
38.
Zhou, AL,
Egginton S,
Brown MD,
and
Hudlicka O.
Capillary growth in overloaded, hypertrophic adult rat skeletal muscle: an ultrastructural study.
Anat Rec
252:
49-63,
1998[Medline].
This article has been cited by other articles:
|
|
 |
|
  W. Mohl, S. Mina, D. Milasinovic, H. Kasahara, and S. Wei The legacy of coronary sinus interventions: Endogenous cardioprotection and regeneration beyond stem cell research. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1131 - 1135. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zheng, L. P. Christensen, and R. J. Tomanek Differential effects of cyclic and static stretch on coronary microvascular endothelial cell receptors and vasculogenic/angiogenic responses Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H794 - H800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kivela, H. Kyrolainen, H. Selanne, P. V. Komi, H. Kainulainen, and V. Vihko A single bout of exercise with high mechanical loading induces the expression of Cyr61/CCN1 and CTGF/CCN2 in human skeletal muscle J Appl Physiol, October 1, 2007; 103(4): 1395 - 1401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Hasaneen, S. Zucker, R. Z. Lin, G. G. Vaday, R. A. Panettieri, and H. D. Foda Angiogenesis is induced by airway smooth muscle strain Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L1059 - L1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Heinemeier, J. L. Olesen, F. Haddad, H. Langberg, M. Kjaer, K. M. Baldwin, and P. Schjerling Expression of collagen and related growth factors in rat tendon and skeletal muscle in response to specific contraction types J. Physiol., August 1, 2007; 582(3): 1303 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Cummins, N. von Offenberg Sweeney, M. T. Killeen, Y. A. Birney, E. M. Redmond, and P. A. Cahill Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H28 - H42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Izumiya, I. Shiojima, K. Sato, D. B. Sawyer, W. S. Colucci, and K. Walsh Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload Hypertension, May 1, 2006; 47(5): 887 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Lamping, W. Zheng, D. Xing, L. P. Christensen, J. Martins, and R. J. Tomanek Bradycardia Stimulates Vascular Growth During Gradual Coronary Occlusion Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2122 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Maloyan, L. Eli-Berchoer, G. L. Semenza, G. Gerstenblith, M. D. Stern, and M. Horowitz HIF-1{alpha}-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart Physiol Genomics, September 21, 2005; 23(1): 79 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Mata-Greenwood, A. Grobe, S. Kumar, Y. Noskina, and S. M. Black Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-{beta}1 and reactive oxygen species: a requirement for NAD(P)H oxidase Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L288 - L289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. I. Dedkov, L. P. Christensen, R. M. Weiss, and R. J. Tomanek Reduction of heart rate by chronic {beta}1-adrenoceptor blockade promotes growth of arterioles and preserves coronary perfusion reserve in postinfarcted heart Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2684 - H2693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Simons Angiogenesis: Where Do We Stand Now? Circulation, March 29, 2005; 111(12): 1556 - 1566. [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Annex and M. Simons Growth factor-induced therapeutic angiogenesis in the heart: protein therapy Cardiovasc Res, February 15, 2005; 65(3): 649 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zheng, L. P. Christensen, and R. J. Tomanek Stretch induces upregulation of key tyrosine kinase receptors in microvascular endothelial cells Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2739 - H2745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mura, C. C. dos Santos, D. Stewart, and M. Liu Vascular endothelial growth factor and related molecules in acute lung injury J Appl Physiol, November 1, 2004; 97(5): 1605 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Prior, H. T. Yang, and R. L. Terjung What makes vessels grow with exercise training? J Appl Physiol, September 1, 2004; 97(3): 1119 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lei, R. Zhou, W. Zheng, L. P. Christensen, R. M. Weiss, and R. J. Tomanek Bradycardia Induces Angiogenesis, Increases Coronary Reserve, and Preserves Function of the Postinfarcted Heart Circulation, August 17, 2004; 110(7): 796 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wang, C. Jiao, H. D. Hanlon, W. Zheng, R. J. Tomanek, and G. C. Schatteman Mechanical, cellular, and molecular factors interact to modulate circulating endothelial cell progenitors Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1985 - H1993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. KJAeR Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading Physiol Rev, April 1, 2004; 84(2): 649 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Heinemeier, H. Langberg, J. L. Olesen, and M. Kjaer Role of TGF-{beta}1 in relation to exercise-induced type I collagen synthesis in human tendinous tissue J Appl Physiol, December 1, 2003; 95(6): 2390 - 2397. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Wada, S. G. Willet, and D. Bader Coronary Vessel Development: A Unique Form of Vasculogenesis Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2138 - 2145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Birukov, J. R. Jacobson, A. A. Flores, S. Q. Ye, A. A. Birukova, A. D. Verin, and J. G. N. Garcia Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L785 - L797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. U. Gurkan, C. O'Donnell, R. Brower, E. Ruckdeschel, and P. M. Becker Differential effects of mechanical ventilatory strategy on lung injury and systemic organ inflammation in mice Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L710 - L718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Mata-Greenwood, B. Meyrick, R. H. Steinhorn, J. R. Fineman, and S. M. Black Alterations in TGF-{beta}1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L209 - L221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Mata-Greenwood, B. Meyrick, S. J. Soifer, J. R. Fineman, and S. M. Black Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L222 - L231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Lloyd, B. M. Prior, H. T. Yang, and R. L. Terjung Angiogenic growth factor expression in rat skeletal muscle in response to exercise training Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1668 - H1678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, W. Zheng, L. P. Christensen, and R. J. Tomanek DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H613 - H618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Lavelin, N. Meiri, M. Einat, O. Genina, and M. Pines Mechanical strain regulation of the chicken glypican-4 gene expression in the avian eggshell gland Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R853 - R861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Rivilis, M. Milkiewicz, P. Boyd, J. Goldstein, M. D. Brown, S. Egginton, F. M. Hansen, O. Hudlicka, and T. L. Haas Differential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesis Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1430 - H1438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Kim, Y.-S. Cho, Y.-S. Chun, J.-W. Park, and M.-S. Kim Early Expression of Myocardial HIF-1{alpha} in Response to Mechanical Stresses: Regulation by Stretch-Activated Channels and the Phosphatidylinositol 3-Kinase Signaling Pathway Circ. Res., February 8, 2002; 90 (2): e25 - e33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Amaral, P. E. Papanek, and A. S. Greene Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1163 - H1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Kim, Y.-S. Cho, Y.-S. Chun, J.-W. Park, and M.-S. Kim Early Expression of Myocardial HIF-1{alpha} in Response to Mechanical Stresses: Regulation by Stretch-Activated Channels and the Phosphatidylinositol 3-Kinase Signaling Pathway Circ. Res., February 8, 2002; 90 (2): e25 - e33. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
